BlackRock’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $77.6M | Buy |
4,562,487
+266,197
| +6% | +$4.41M | ﹤0.01% | 2376 |
|
|
2026
Q1 | $69.7M | Buy |
4,296,290
+245,765
| +6% | +$4.35M | ﹤0.01% | 2319 |
|
|
2025
Q4 | $75.8M | Sell |
4,050,525
-18,469
| -0.5% | -$306K | ﹤0.01% | 2271 |
|
|
2025
Q3 | $59.4M | Sell |
4,068,994
-70,031
| -2% | -$885K | ﹤0.01% | 2398 |
|
|
2025
Q2 | $45.7M | Buy |
4,139,025
+687,696
| +20% | +$6.69M | ﹤0.01% | 2501 |
|
|
2025
Q1 | $30.8M | Sell |
3,451,329
-260,974
| -7% | -$2.43M | ﹤0.01% | 2676 |
|
|
2024
Q4 | $34.9M | Sell |
3,712,303
-19,002
| -0.5% | -$173K | ﹤0.01% | 2683 |
|
|
2024
Q3 | $30.1M | Sell |
3,731,305
-48,855
| -1% | -$423K | ﹤0.01% | 2784 |
|
|
2024
Q2 | $32.1M | Sell |
3,780,160
-428,177
| -10% | -$3.86M | ﹤0.01% | 2703 |
|
|
2024
Q1 | $37.7M | Sell |
4,208,337
-379,497
| -8% | -$3.52M | ﹤0.01% | 2615 |
|
|
2023
Q4 | $51.6M | Buy |
4,587,834
+20,904
| +0.5% | +$210K | ﹤0.01% | 2453 |
|
|
2023
Q3 | $39.4M | Sell |
4,566,930
-514,285
| -10% | -$4.97M | ﹤0.01% | 2540 |
|
|
2023
Q2 | $52.6M | Sell |
5,081,215
-61,462
| -1% | -$679K | ﹤0.01% | 2448 |
|
|
2023
Q1 | $55.8M | Sell |
5,142,677
-188,100
| -4% | -$1.99M | ﹤0.01% | 2371 |
|
|
2022
Q4 | $59.8M | Buy |
5,330,777
+223,250
| +4% | +$2.35M | ﹤0.01% | 2339 |
|
|
2022
Q3 | $51.8M | Buy |
5,107,527
+84,787
| +2% | +$794K | ﹤0.01% | 2409 |
|
|
2022
Q2 | $45.5M | Buy |
5,022,740
+93,600
| +2% | +$862K | ﹤0.01% | 2559 |
|
|
2022
Q1 | $47.1M | Sell |
4,929,140
-73,223
| -1% | -$718K | ﹤0.01% | 2627 |
|
|
2021
Q4 | $55.3M | Sell |
5,002,363
-102,096
| -2% | -$890K | ﹤0.01% | 2598 |
|
|
2021
Q3 | $37.8M | Buy |
5,104,459
+583,752
| +13% | +$6.53M | ﹤0.01% | 2848 |
|
|
2021
Q2 | $65.6M | Sell |
4,520,707
-113,428
| -2% | -$2.13M | ﹤0.01% | 2518 |
|
|
2021
Q1 | $94.6M | Buy |
4,634,135
+142,940
| +3% | +$2.72M | ﹤0.01% | 2227 |
|
|
2020
Q4 | $79.8M | Buy |
4,491,195
+171,761
| +4% | +$3.08M | ﹤0.01% | 2209 |
|
|
2020
Q3 | $63.9M | Sell |
4,319,434
-58,493
| -1% | -$1.1M | ﹤0.01% | 2148 |
|
|
2020
Q2 | $91.9M | Sell |
4,377,927
-4,402,863
| -50% | -$113M | ﹤0.01% | 1888 |
|
|
2020
Q1 | $203M | Buy |
8,780,790
+4,951,711
| +129% | +$124M | 0.01% | 1162 |
|
|
2019
Q4 | $99.1M | Sell |
3,829,079
-27,551
| -0.7% | -$535K | ﹤0.01% | 1967 |
|
|
2019
Q3 | $75.1M | Buy |
3,856,630
+23,948
| +0.6% | +$484K | ﹤0.01% | 2056 |
|
|
2019
Q2 | $62.6M | Buy |
3,832,682
+116,009
| +3% | +$2.35M | ﹤0.01% | 2197 |
|
|
2019
Q1 | $84.3M | Sell |
3,716,673
-146,403
| -4% | -$3.71M | ﹤0.01% | 1976 |
|
|
2018
Q4 | $98.9M | Buy |
3,863,076
+29,667
| +0.8% | +$801K | 0.01% | 1808 |
|
|
2018
Q3 | $125M | Buy |
3,833,409
+82,620
| +2% | +$2.25M | 0.01% | 1809 |
|
|
2018
Q2 | $85.1M | Buy |
3,750,789
+167,747
| +5% | +$3.98M | ﹤0.01% | 2050 |
|
|
2018
Q1 | $86.9M | Sell |
3,583,042
-160,913
| -4% | -$4.42M | ﹤0.01% | 1948 |
|
|
2017
Q4 | $104M | Sell |
3,743,955
-61,272
| -2% | -$1.81M | 0.01% | 1855 |
|
|
2017
Q3 | $130M | Buy |
3,805,227
+166,389
| +5% | +$5.44M | 0.01% | 1664 |
|
|
2017
Q2 | $145M | Buy |
3,638,838
+126,393
| +4% | +$4.86M | 0.01% | 1544 |
|
|
2017
Q1 | $129M | Buy |
3,512,445
+3,509,456
| +117,412% | +$112M | 0.01% | 1597 |
|
|
2016
Q4 | $96K | Buy |
2,989
+59
| +2% | +$1.83K | ﹤0.01% | 2566 |
|
|
2016
Q3 | $106K | Sell |
2,930
-891
| -23% | -$24.8K | ﹤0.01% | 2548 |
|
|
2016
Q2 | $87K | Buy |
3,821
+2,042
| +115% | +$44.1K | ﹤0.01% | 2624 |
|
|
2016
Q1 | $33K | Buy |
1,779
+1,083
| +156% | +$17.7K | ﹤0.01% | 2589 |
|
|
2015
Q4 | $11K | Hold |
696
| – | – | ﹤0.01% | 2858 |
|
|
2015
Q3 | $8K | Hold |
696
| – | – | ﹤0.01% | 2842 |
|
|
2015
Q2 | $9K | Hold |
696
| – | – | ﹤0.01% | 2880 |
|
|
2015
Q1 | $12K | Hold |
696
| – | – | ﹤0.01% | 2642 |
|
|
2014
Q4 | $10K | Hold |
696
| – | – | ﹤0.01% | 2780 |
|
|
2014
Q3 | $16K | Hold |
696
| – | – | ﹤0.01% | 2456 |
|
|
2014
Q2 | $23K | Buy |
+696
| New | +$21K | ﹤0.01% | 2303 |
|
Other funds holding TBPH
MAP
WAM
NM
ICM
BlackRock's TBPH Position: Q2 2026 in Review
BlackRock increased its Theravance Biopharma (TBPH) stake by 6.2% in Q2 2026, buying an estimated $4.41M and bringing the position to 4,562,487 shares worth $77.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2376.
BlackRock first reported a position in TBPH in Q2 2014 and has held it in 49 quarters since. The position peaked at $203M in Q1 2020. 179 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.
- BlackRock held 4,562,487 shares of Theravance Biopharma worth $77.6M as of Q2 2026.
- BlackRock bought 266,197 Theravance Biopharma shares in Q2 2026, an estimated $4.41M.
- Theravance Biopharma made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2376 holding.
- BlackRock first reported a position in Theravance Biopharma in Q2 2014 and has held it in 49 quarters since.
- BlackRock's Theravance Biopharma position peaked at $203M in Q1 2020.
- 179 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.